USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR TREATING SYSTEMIC MASTOCYTOSIS Russian patent published in 2012 - IPC A61K31/506 A61P35/00 C07D401/14 

Abstract RU 2445960 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to the use of pyrimidylaminobenzamide derivatives, particularly 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide of formula

, or its pharmaceutically acceptable salt for preparing drugs applicable for treating and preventing systemic mastocytosis. The invention refers to a drug, a method of treating or preventing systemic mastocytosis. The invention also refers to a combination to be used for treating systemic mastocytosis containing the compound of formula (II) and imanitib taken in a therapeutically efficient amount.

EFFECT: compound (II) and combination are applicable in treating systemic mastocytosis which is characterised by resistance to imanitib and preferentially bound with FIPlLl-PDGFRa hybrid gene.

12 cl, 1 ex

Similar patents RU2445960C2

Title Year Author Number
PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR NEUROFIBROMATOSIS 2006
  • Manli Pol U.
RU2450814C2
COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND IMANITIB DERIVATIVES FOR TREATMENT OR PREVENTION OF PROLIFERATIVE DISEASES 2006
  • Olland Lila
  • Manli Pol U.
  • Mestan Jurgen
RU2430727C2
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR 2007
  • Manli Pol U.
RU2481840C2
METHOD FOR TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY ACTIVITY OF KINASE BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R 2010
  • Nil Gallager
  • Ofeliya In
RU2625835C2
COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND mTOR KINASE INHIBITOR 2006
  • Manli Pol U.
  • Lane Khajdi
RU2443418C2
APPLICATION OF PYRIMIDYLAMINOBENZAMIDES FOR TREATMENT OF DISEASES SENSITIVE TO MODULATION OF KINASE Tie-2 ACTIVITY 2006
  • Manli Pol U.
  • Martini-Baron Georg
  • Mestan Jurgen
RU2404776C2
USING DERIVATIVES OF N-PHENYL-2-PYRIMIDINEAMINE AGAINST MASTOCYTE-BASE DISEASES SIMILAR TO ALLERGIC DISTURBANCE 2002
  • Koike Kenichi
  • Komijama Atsushi
  • Takeuchi Kouichi
  • Khajnrikh Majkl
  • Nakadzhima Motovo
RU2304436C2
COMPOSITIONS AND METHODS OF TREATING KIT- AND PDGFRα-MEDIATED DISEASES 2020
  • Kim, Dzhozef, L.
  • Dajnin, Tomas, A.
  • Guzi, Timoti
RU2817354C2
PYRAZOLE DERIVATIVES AND THEIR USE 2020
  • Lyu, Tsin Sun
  • Lyu, Tszin
  • Li, Si Syan
  • Van, Ao Li
  • Tszou, Fen Min
  • Chen, Chen
  • Lyu, Tsin Van
  • Lyu, Tszyuan
  • Tsao, Tszyan Yan
  • Van, Ven Lyan
  • Tsi, Shuan
  • Van, Ven Chao
  • Van, Bej Lej
  • Van, Li
RU2805207C1
COMBINATION CONTAINING IRON COMPLEX AND ANTINEOPLASTIC AGENT, AND USE THEREOF 2007
  • Nikk Khanspeter
RU2469721C2

RU 2 445 960 C2

Authors

Olland Lejla

Fabbro Doriano

Mestan Jurgen

Manli Pol U.

Dates

2012-03-27Published

2006-05-01Filed